ATG5 and hepatocellular carcinoma: MiR-30a inhibits autophagy in chronic myeloid leukemia and hepatocellular carcinoma (HCC) cells by selectively blocking BECN1 and ATG5, which are needed for autophagy nucleation and elongation stages respectively (Yu et al., 2012; Fu et al., 2018b).